Sun Pharma enters pact with Forest Labs,H Lundbeck for Lexapro

MUMBAI: Sun Pharma and its US subsidiary Caraco Pharma have entered into agreements with Forest Laboratoriesa and H Lundbeck to settle legal proceedings related to Lexapro tablets.

According to the agreements, Sun would licence to Lundbeck certain patent applications related to the synthesis of escitalopram and citalopram in exchange for an upfront payment and royalties on sales, the company said in a release.

Caraco would take over commercialisation and sale of several products from Forest's Inwood business. Caraco would pay Forest an advance agaisnt royalties on sales of these products, it said.